Literature DB >> 20732499

Human thymus mesenchymal stromal cells augment force production in self-organized cardiac tissue.

Claus S Sondergaard1, Chani J Hodonsky, Luda Khait, John Shaw, Bedabrata Sarkar, Ravi Birla, Edward Bove, Jan Nolta, Ming-Sing Si.   

Abstract

BACKGROUND: Mesenchymal stromal cells have been recently isolated from thymus gland tissue discarded after surgical procedures. The role of this novel cell type in heart regeneration has yet to be defined. The purpose of this study was to evaluate the therapeutic potential of human thymus-derived mesenchymal stromal cells using self-organized cardiac tissue as an in vitro platform for quantitative assessment.
METHODS: Mesenchymal stromal cells were isolated from discarded thymus tissue from neonates undergoing heart surgery and were incubated in differentiation media to demonstrate multipotency. Neonatal rat cardiomyocytes self-organized into cardiac tissue fibers in a custom culture dish either alone or in combination with varying numbers of mesenchymal stromal cells. A transducer measured force generated by spontaneously contracting self-organized cardiac tissue fibers. Work and power outputs were calculated from force tracings. Immunofluorescence was performed to determine the fate of the thymus-derived mesenchymal stromal cells.
RESULTS: Mesenchymal stromal cells were successfully isolated from discarded thymus tissue. After incubation in differentiation media, mesenchymal stromal cells attained the expected phenotypes. Although mesenchymal stromal cells did not differentiate into mature cardiomyocytes, addition of these cells increased the rate of fiber formation, force production, and work and power outputs. Self-organized cardiac tissue containing mesenchymal stromal cells acquired a defined microscopic architecture.
CONCLUSIONS: Discarded thymus tissue contains mesenchymal stromal cells, which can augment force production and work and power outputs of self-organized cardiac tissue fibers by several-fold. These findings indicate the potential utility of mesenchymal stromal cells in treating heart failure. 2010 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20732499      PMCID: PMC3021786          DOI: 10.1016/j.athoracsur.2010.04.080

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  17 in total

1.  Self-organization of rat cardiac cells into contractile 3-D cardiac tissue.

Authors:  Keith Baar; Ravi Birla; Marvin O Boluyt; Gregory H Borschel; Ellen M Arruda; Robert G Dennis
Journal:  FASEB J       Date:  2004-12-01       Impact factor: 5.191

Review 2.  Mesenchymal stem cells: future source for reparative medicine.

Authors:  Rinky Bhatia; Joshua M Hare
Journal:  Congest Heart Fail       Date:  2005 Mar-Apr

3.  Isolation and phenotypical characterization of mesenchymal stem cells from human fetal thymus.

Authors:  A A Rzhaninova; S N Gornostaeva; D V Goldshtein
Journal:  Bull Exp Biol Med       Date:  2005-01       Impact factor: 0.804

4.  Mitochondrial transfer between cells can rescue aerobic respiration.

Authors:  Jeffrey L Spees; Scott D Olson; Mandolin J Whitney; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

Review 5.  Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy.

Authors:  Jeffrey M Zimmet; Joshua M Hare
Journal:  Basic Res Cardiol       Date:  2005-11       Impact factor: 17.165

6.  Effect of thyroid hormone on the contractility of self-organized heart muscle.

Authors:  Luda Khait; Ravi K Birla
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-06-05       Impact factor: 2.416

7.  Characterization and histological localization of multipotent mesenchymal stromal cells in the human postnatal thymus.

Authors:  Moubarak Mouiseddine; Noëlle Mathieu; Johanna Stefani; Christelle Demarquay; Jean-Marc Bertho
Journal:  Stem Cells Dev       Date:  2008-12       Impact factor: 3.272

8.  Human neonatal thymus-derived mesenchymal stromal cells: characterization, differentiation, and immunomodulatory properties.

Authors:  Matthias Siepe; Andreas R Thomsen; Natalie Duerkopp; Ulf Krause; Katharina Förster; Philip Hezel; Friedhelm Beyersdorf; Christian Schlensak; Norbert P Südkamp; Roland Bosse; Philipp Niemeyer
Journal:  Tissue Eng Part A       Date:  2009-07       Impact factor: 3.845

9.  Modulating the functional performance of bioengineered heart muscle using growth factor stimulation.

Authors:  Yen-Chih Huang; Luda Khait; Ravi K Birla
Journal:  Ann Biomed Eng       Date:  2008-05-24       Impact factor: 3.934

10.  Left ventricular relaxation in the filling and nonfilling intact canine heart.

Authors:  E L Yellin; M Hori; C Yoran; E H Sonnenblick; S Gabbay; R W Frater
Journal:  Am J Physiol       Date:  1986-04
View more
  8 in total

1.  Characterization and angiogenic potential of human neonatal and infant thymus mesenchymal stromal cells.

Authors:  Shuyun Wang; Lakshmi Mundada; Sean Johnson; Joshua Wong; Russell Witt; Richard G Ohye; Ming-Sing Si
Journal:  Stem Cells Transl Med       Date:  2015-02-23       Impact factor: 6.940

Review 2.  Combination Therapy of Stem Cell-derived Exosomes and Biomaterials in the Wound Healing.

Authors:  Ali Golchin; Forough Shams; Arefeh Basiri; Parviz Ranjbarvan; Samaneh Kiani; Roya Sarkhosh-Inanlou; Abdolreza Ardeshirylajimi; Shiva Gholizadeh-Ghaleh Aziz; Sanaz Sadigh; Yousef Rasmi
Journal:  Stem Cell Rev Rep       Date:  2022-01-26       Impact factor: 6.692

3.  Effects of scaffold material used in cardiovascular surgery on mesenchymal stem cells and cardiac progenitor cells.

Authors:  Chani Hodonsky; Lakshmi Mundada; Shuyun Wang; Russell Witt; Gary Raff; Sunjay Kaushal; Ming-Sing Si
Journal:  Ann Thorac Surg       Date:  2014-12-12       Impact factor: 4.330

4.  Contractile and electrophysiologic characterization of optimized self-organizing engineered heart tissue.

Authors:  Claus Svane Sondergaard; Grant Mathews; Lianguo Wang; Angela Jeffreys; Amrit Sahota; Moira Wood; Crystal M Ripplinger; Ming-Sing Si
Journal:  Ann Thorac Surg       Date:  2012-07-12       Impact factor: 4.330

5.  Mesenchymal Stem Cells Reversed Morphine Tolerance and Opioid-induced Hyperalgesia.

Authors:  Zhen Hua; LiPing Liu; Jun Shen; Kathleen Cheng; Aijun Liu; Jing Yang; Lina Wang; Tingyu Qu; HongNa Yang; Yan Li; Haiyan Wu; John Narouze; Yan Yin; Jianguo Cheng
Journal:  Sci Rep       Date:  2016-08-24       Impact factor: 4.379

6.  Tissue-specific angiogenic and invasive properties of human neonatal thymus and bone MSCs: Role of SLIT3-ROBO1.

Authors:  Shuyun Wang; Shan Huang; Sean Johnson; Vadim Rosin; Jeffrey Lee; Eric Colomb; Russell Witt; Alexander Jaworski; Stephen J Weiss; Ming-Sing Si
Journal:  Stem Cells Transl Med       Date:  2020-05-29       Impact factor: 6.940

Review 7.  Clinical applications of mesenchymal stem cells in chronic diseases.

Authors:  Andrea Farini; Clementina Sitzia; Silvia Erratico; Mirella Meregalli; Yvan Torrente
Journal:  Stem Cells Int       Date:  2014-04-30       Impact factor: 5.443

8.  Human Neonatal Thymus Mesenchymal Stem Cells Promote Neovascularization and Cardiac Regeneration.

Authors:  Shuyun Wang; Shan Huang; Lianghui Gong; Zhize Yuan; Joshua Wong; Jeffrey Lee; Ming-Sing Si
Journal:  Stem Cells Int       Date:  2018-09-16       Impact factor: 5.443

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.